Skip to main content

Table 1 Drug resistance features of clinical isolates, alongside their MIC50, MIC90 values

From: Understanding the clinical and molecular epidemiological characteristics of carbapenem-resistant Acinetobacter baumannii infections within intensive care units of three teaching hospitals

Antibiotics

R (n, %)

MIC50

MIC90

Ceftazidime

92, 100%

≥ 64

≥ 64

Cefepime

88, 96%

≥ 32

≥ 64

Imipenem

92, 100%

≥ 16

≥ 64

Meropenem

92, 100%

≥ 16

≥ 64

Tetracycline

82, 89%

≥ 16

≥ 16

Minocycline

26, 28%

≥ 8

≥ 16

Gentamicin

82, 89%

> 32

> 32

Amikacin

76, 83%

≥ 8

≥ 64

Levofloxacin

84, 91%

≥ 8

≥ 16